Episode 537 - Uromigos Live 2026 – Sequencing of Therapy Across the Continuum of Advanced Prostate Cancer
From The Uromigos · · 49 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Several third agents added to the ADT/ARPI backbone in mHSPC have emerged in the last year including radioligands and PARP inhibitors. Navigating application to individual patients is discussed by our expert panel.